Engineers Gate Manager LP Corbus Pharmaceuticals Holdings, Inc. Transaction History

Engineers Gate Manager LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.32 - $0.67 $6,432 - $13,467	-20,101 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.6 - $1.11 $12,060 - $22,312	20,101 New	20,101 $12,000
Q4 2020 Feb 16, 2021	SELL	$0.94 - $1.89 $24,083 - $48,423	-25,621 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$1.5 - $9.38 $10,827 - $67,704	7,218 Added 39.22%	25,621 $46,000
Q2 2020 Aug 17, 2020	BUY	$4.79 - $8.39 $23,485 - $41,136	4,903 Added 36.32%	18,403 $154,000
Q1 2020 May 15, 2020	BUY	$3.44 - $7.21 $46,440 - $97,335	13,500 New	13,500 $71,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.56B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.